1989Obstetrical & Gynecological SurveyRequires access

Dilemmas in the Pharmacological Management of Preterm Labor

Edward A. Graber

Open publisher page 8 citations

Abstract

It is the thesis of the author that the use of Ritodrine in the treatment of premature labor is potentially dangerous and possibly even lethal. Ritodrine is being overused in the attempt to control and delay premature labor. Only 25 to 50 per cent of patients complaining of premature labor pains actually proceed to true preterm labor. Because there is no definitive screening test to firmly establish the diagnosis of preterm labor, many women are treated unnecessarily with a drug that many obstetricians question as to its efficacy, safety, and cost. If it is used, it must be in a hospital with adequate facilities both in manpower and the ability to identify and treat the medical and obstetrical complications. Ritodrine is too potentially dangerous to be used as an attempt to "do something" it there are questionable indications.

About this research paper

What this paper is about

It is the thesis of the author that the use of Ritodrine in the treatment of premature labor is potentially dangerous and possibly even lethal. Ritodrine is being overused in the attempt to control and delay premature labor. Only 25 to 50 per cent of patients complaining of premature labor pains actually proceed to true preterm labor. Because there is no definitive screening test to firmly establish the diagnosis of preterm labor, many women are treated unnecessarily with a drug that many obstetricians question as to its efficacy, safety, and cost. If it is used, it must be in a hospital with adequate facilities both in manpower and the ability to identify and treat the medical and obstetrical complications. Ritodrine is too potentially dangerous to be used as an attempt to "do something" it there are questionable indications.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

It is the thesis of the author that the use of Ritodrine in the treatment of premature labor is potentially dangerous and possibly even lethal. Ritodrine is being overused in the attempt to control and delay premature labor. Only 25 to 50 per cent of patients complaining of premature labor pains actually proceed to true preterm labor. Because there is no definitive screening test to firmly establish the diagnosis of preterm labor, many women are treated unnecessarily with a drug that many obstetricians question as to its efficacy, safety, and cost. If it is used, it must be in a hospital with adequate facilities both in manpower and the ability to identify and treat the medical and obstetrical complications. Ritodrine is too potentially dangerous to be used as an attempt to "do something" it there are questionable indications.

Key concepts: Ritodrine, Medicine, Premature labor, Preterm labor, Intensive care medicine, Obstetrics, Preterm labour, Pregnancy

Related papers

Back to paper searchBrowse research topicsOriginal source
Dilemmas in the Pharmacological Management of Preterm Labor — Research Paper | ScholarLens